Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELIQUIS vs ELRANATAMAB-BCMM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ELIQUIS vs ELRANATAMAB-BCMM: Safety Overview

Metric ELIQUIS ELRANATAMAB-BCMM
Total FAERS Reports 1,430 570
Deaths Reported 98 120
Death Rate 6.9% 21.1%
Hospitalizations 273 168
Average Patient Age 76.5 yrs 69.5 yrs
% Female Patients 100.0% 49.4%